
Rolnik Pharma Private Limited
About Rolnik Pharma Private Limited
Data last updated:
Rolnik Pharma Private Limited is a private limited company based in Ambala Cantt, Haryana, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 07 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304HR2017PTC069407. Its GSTIN is 06AAICR3444C1ZN (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Bhupinder Singh and Rajesh Bhardwaj.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4 Shiv Partap Nagar, Ambala Cantt, Haryana, India – 133001.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.83 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹46,896 (net margin 0.3%) and EBITDA of ₹66,981 (EBITDA margin 0.4%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 7% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Rolnik Pharma Private Limited's registered office is in Ambala Cantt, Haryana. Its e-mail address is in the company report.
- Email
- Registered Address4 Shiv Partap Nagar, Ambala Cantt, Haryana, India – 133001
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of Rolnik Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rolnik Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rolnik Pharma Private Limited, buy the company report.
Financials of Rolnik Pharma Private Limited
FY 2025 filings availableRolnik Pharma Private Limited reported revenue of ₹1.83 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 7% growth in the latest year. EBITDA fell 71% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹66,981 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹46,896 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rolnik Pharma Private Limited, buy the company report.
Board of directors of Rolnik Pharma Private Limited
Rolnik Pharma has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhupinder Singh | Director | 14 Sep 2017 | 9 Years 1 Months | Current |
| Rajesh Bhardwaj | Director | 07 Jun 2017 | 9 Years 4 Months | Current |
| Raj Bahadur Singh | Director | 14 Sep 2017 | 9 Years 1 Months | Current |
| Tarun Kumar | Director | 07 Jun 2017 | 9 Years 4 Months | Current |
Peer comparison
Rolnik Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anugrah Vyapaar Private Limited | ₹1.83 Cr (FY 2025) | 313.0% | Kolkata, West Bengal, India | |||
| Laser Holograms Pvt Ltd | ₹1.83 Cr (FY 2025) | 12.0% | Kolkata, West Bengal, India | |||
| Reverie Constructions & Solar Solutions Private Limited | ₹1.83 Cr (FY 2024) | -24.0% | Ernakulam, Kerala, India | |||
| Assent Concerns Private Limited | ₹1.83 Cr (FY 2024) | -41.0% | Sanga Reddy, Hyderabad, Telangana, India | |||
| Vidul Farmer Producer Company Limited | ₹1.83 Cr (FY 2025) | 63.0% | Vidul, Maharashtra, India | |||
| Rolnik Pharma Private Limitedthis company | ₹1.83 Cr (FY 2025) | ₹46,896 | 0.3% | 7.0% | Ambala Cantt, Haryana, India | |
| Velani Lifestyle Private Limited | ₹1.83 Cr (FY 2021) | 2579.0% | Ahmedabad, Gujarat, India | |||
| BWH Equipment Private Limited | ₹1.83 Cr (FY 2023) | 7409.0% | North 24 Parganas, West Bengal, India | |||
| Jesko International Private Limited | ₹1.83 Cr (FY 2024) | -26.0% | Thane, Maharashtra, India | |||
| Well Stone Constructions Private Limited | ₹1.83 Cr (FY 2018) | -60.0% | Dholpur, Rajasthan, India | |||
| Fare Tradebasket India Private Limited | ₹1.83 Cr (FY 2025) | 80.0% | Bhopal, Madhya Pradesh, India |
To see the full peer comparison of Rolnik Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rolnik Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rolnik Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rolnik Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAICR3444C1ZN | Haryana | Active | 02 Aug 2017 |
To see the full GST registrations and return filing status of Rolnik Pharma Private Limited, buy the company report.
Recent activity
Rolnik Pharma Private Limited has 4 board changes on record since 2017: 4 appointments. The latest: Bhupinder Singh was appointed as Director on 14 Sep 2017.
Frequently asked questions
Rolnik Pharma is an active private limited company based in Ambala Cantt, Haryana, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 07 June 2017 (9+ years old) and is registered under CIN U24304HR2017PTC069407.
Rolnik Pharma has 4 current directors:
- Bhupinder Singh - Director
- Rajesh Bhardwaj - Director
- Raj Bahadur Singh - Director
- Tarun Kumar - Director
The latest financial statements of Rolnik Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Rolnik Pharma is 06AAICR3444C1ZN, registered in Haryana.
The CIN (Corporate Identification Number) of Rolnik Pharma is U24304HR2017PTC069407. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rolnik Pharma was incorporated on 07 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Rolnik Pharma by revenue are Anugrah Vyapaar Private Limited, Laser Holograms Pvt Ltd, Reverie Constructions & Solar Solutions Private Limited, Assent Concerns Private Limited, Vidul Farmer Producer Company Limited and 5 more, all in the same principal business activity (wholesale trading).
Bhupinder Singh was appointed as Director on 14 Sep 2017. Raj Bahadur Singh was appointed as Director on 14 Sep 2017. Rajesh Bhardwaj was appointed as Director on 07 Jun 2017. Rolnik Pharma has 4 board changes on record in total.
The registered office of Rolnik Pharma is at 4 Shiv Partap Nagar, Ambala Cantt, Haryana, India – 133001.
Rolnik Pharma operates in the food and beverages industry, in the manufacturing segment.
The compliance status of Rolnik Pharma is compliant as of 26 August 2026. The company is actively filing with the Registrar of Companies.